Ansem is bullish on Eli Lilly and Company (LLY), specifically highlighting "peptides & fat loss drugs." The accompanying chart shows LLY trading around $1,019.57, near its all-time high, indicating strong upward momentum. This suggests a potential long opportunity in LLY driven by its pipeline in weight loss medications.